BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14981076)

  • 1. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate.
    El Fadili A; Kündig C; Roy G; Ouellette M
    J Biol Chem; 2004 Apr; 279(18):18575-82. PubMed ID: 14981076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
    Kündig C; Leblanc E; Papadopoulou B; Ouellette M
    Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
    El-Fadili A; Richard D; Kündig C; Ouellette M
    Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae.
    Kündig C; Haimeur A; Légaré D; Papadopoulou B; Ouellette M
    EMBO J; 1999 May; 18(9):2342-51. PubMed ID: 10228149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
    Bhattacharya A; Leprohon P; Ouellette M
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
    Cunningham ML; Beverley SM
    Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
    Nare B; Hardy LW; Beverley SM
    J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
    Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterin and folate reduction by the Leishmania tarentolae H locus short-chain dehydrogenase/reductase PTR1.
    Wang J; Leblanc E; Chang CF; Papadopoulou B; Bray T; Whiteley JM; Lin SX; Ouellette M
    Arch Biochem Biophys; 1997 Jun; 342(2):197-202. PubMed ID: 9186479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
    Chang CF; Bray T; Whiteley JM
    Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
    Nare B; Luba J; Hardy LW; Beverley S
    Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity S-Adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) family.
    Dridi L; Ahmed Ouameur A; Ouellette M
    J Biol Chem; 2010 Jun; 285(26):19767-75. PubMed ID: 20406813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis and complex gene rearrangements of the folate/biopterin transporter (FBT) gene family in the protozoan parasite Leishmania.
    Ouameur AA; Girard I; Légaré D; Ouellette M
    Mol Biochem Parasitol; 2008 Dec; 162(2):155-64. PubMed ID: 18796316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delving in folate metabolism in the parasite Leishmania major through a chemogenomic screen and methotrexate selection.
    Bigot S; Leprohon P; Ouellette M
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011458. PubMed ID: 37384801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of Leishmania cells to in vitro culture results in a more efficient reduction and transport of biopterin.
    Roy G; Kündig C; Olivier M; Papadopoulou B; Ouellette M
    Exp Parasitol; 2001 Mar; 97(3):161-8. PubMed ID: 11312578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
    Robello C; Navarro P; Castanys S; Gamarro F
    Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.